Rise in Pharma Investments will Boost PAP and Paracetamol Market to US$1.7 bn by 2022


Posted August 24, 2017 by hawerr

The Global PAP and paracetamol market was valued at US$0.4 bn and US$0.8 bn, respectively, in 2013 and is projected to reach US$0.7 bn and US$1.0 bn, respectively, in 2022.

 
Paracetamol, also known as acetaminophen, is a pain reliever and an antipyretic. The drug is administered either alone or in combination, or as an alternative to aspirin due to comparatively fewer side effects. Para-aminophenol (PAP) is a final intermediate in the industrial synthesis of paracetamol and is used in the manufacture of products having various application in different sectors such as pharmaceuticals, dye industries, and fine chemicals. The report on the global paracetamol and para-aminophenol market studies the current and future prospects of the market with respect to demand, consumption, and production. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the global paracetamol and para-aminophenol market.

Browse the Comprehensive Details for the Report of PAP and Paracetamol Market: http://www.transparencymarketresearch.com/pap-paracetamol-market.html

Some of the leading players in the global PAP (para-aminophenol) and paracetamol market are Mallinckrodt, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India, and Taixing Yangzi Pharm Chemical Co., Ltd. The highly fragmented markets will witness companies stepping up their supply capabilities through well-established distribution channels and influential marketing strategies to remain relevant, observes Transparency Market Research in a new report.

Need Pain Management Drives PAP and Paracetamol Market

The market drivers for PAP and paracetamol are closely interlinked as 80% of the PAP produced across the globe is used in production of paracetamol. Thus, the overall increase in the production of paracetamol, a commonly used analgesic, is driving the global PAP market. The other increasing end uses of PAP in sulfide dyes, azo dyes, fur dyes, photographic developers, and rubber antioxidants are propelling the consumption of PAP. The high incidence of pain-related diseases and conditions have also increased the uptake of paracetamol in recent years, creating a direct impact on the sales of PAP.

The low production costs in emerging countries such as China and India have made them the focal point of chemical manufacturing activities. The evolving nature of these manufacturing units with diversified production capabilities have also contributed towards high utilization of PAP. The accelerated pace of manufacturing agro-chemicals, pharmaceuticals, and dyes amongst others will collectively lead to growing demand for PAP during the forecast period.

Solvent-free Synthesizing Challenges PAP Market

The shifting focus on synthesizing paracetamol without solvents is expected to hamper the usage of PAP in manufacturing processes, thereby restraining the growth of PAP market in the coming years. Furthermore, growing awareness amongst consumers about side-effects of analgesics is also create a negative sentiment in the paracetamol market. However, efforts channelized towards forward and backward integration will organize businesses in a far more efficient manner.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6763

Asia Pacific Makes Most of Production Opportunities to Maintain Lead

According to the research report, the global paracetamol market is expected to reach US$1,049.7 mn by 2022 as compared to its valuation of US$900.2 mn in 2014. On the other hand, the para-aminophenol market, which was valued at US$452.7 mn in 2014 is expected to reach US$709.2 mn by 2022. Analysts have identified North America as the largest geographical segment in both the markets with the PAP market here poised to reach revenues of US$295.3 mn by 2022 and paracetamol representing an opportunity worth US$437.1 mn by 2022. Meanwhile, Asia Pacific is expected to take up the opportunity of highest production of paracetamol, thus registering a CAGR of 1.9% during the forecast period. This region will also take lead in the PAP market with a steady CAGR of 8.1% between 2014 and 2022.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Health , Medical , News
Tags pap and paracetamol market
Last Updated August 24, 2017